EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

An Exploratory Study of Six-Month Niacinamide Supplementation on Macular Structure and Electrophysiology in Primary Open-Angle Glaucoma

Constantin Alin Nicola, Maria Cristina Marinescu iD, Cristina Alexandrescu, Anne Marie Firan, Walid Alyamani, Mihaela Simona Naidin iD, Radu Constantin Ciuluvica, Radu Antoniu Patrascu, Anca Maria Capraru, Adina Turcu-Stiolica iD

Vision · 28.01.2026 · 10 (1) · 7

DOI: 10.3390/vision10010007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vision, online erschienen am 28.01.2026. Verfasst von Constantin Alin Nicola und 9 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral School, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives: Primary open-angle glaucoma (POAG) is one of the leading ocular diseases leading to irreversible blindness and is often asymptomatic until advanced cases. While intraocular pressure reduction remains the cornerstone of treatment, neuroprotective strategies targeting retinal ganglion cell metabolism are actively investigated. Niacinamide (nicotinamide, vitamin B3), a precursor of NAD+, has shown neuroprotective potential in preclinical models. This exploratory study evaluated the short-term functional, structural, and electrophysiological effects of oral niacinamide supplementation in POAG. Materials and Methods: In this interventional study, patients with POAG received oral niacinamide 500 mg daily for six months. Visual field (VF) global and localized sensitivity (Mean Deviation [MD], Pattern Standard Deviation [PSD]), Optic Coherence Tomography (OCT)-derived peripapillary retinal nerve fiber layer (RNFL) and macular ganglion cell complex (GCC), and Visual evoked potentials (VEP) latency parameters (P2 1.4 Hz, P100 1°, and P100 15′) were assessed at baseline and at six months. Because both eyes from some participants were included, primary longitudinal inference was based on clustered analyses using generalized estimating equations and linear mixed-effects models to account for inter-eye correlation. Eye-level paired analyses were used for exploratory comparison. Change–change relationships across modalities were explored using Spearman correlation.

Results

After accounting for inter-eye correlation, no statistically significant change in MD was detected (mean ΔMD +0.43 dB; GEE p = 0.099; LME p = 0.101), and PSD remained stable. RNFL thickness showed a small decrease (−1.26 µm; GEE p = 0.046), while GCC did not change significantly. VEP P100 latencies remained stable, whereas P2 latency showed a small increase (+3.9 ms; GEE p = 0.039). Correlation analysis revealed a moderate association between changes in GCC and MD (ρ = 0.44), suggesting concordance between macular structural stability and global visual field performance.

Conclusions

When inter-eye correlation is appropriately accounted for, six months of niacinamide supplementation in POAG is associated with overall functional, structural, and electrophysiological stability, without evidence of clinically meaningful improvement or progression. These findings support short-term safety and highlight the importance of clustered analytical approaches and macular-centered biomarkers in future glaucoma neuroprotection trials.

Schlagwörter

Stichwörter der Autor:innen

glaucomaniacinamidenicotinamideoptical coherence tomographyvisual fieldvisually evoked potentialsvitamin B3

Autor:innen und Institutionen

  • Doctoral School, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
  • Discipline of Medical Physiology, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.
  • Department of Ophthalmology, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.
  • Barnsley Hospital NHS Foundation Trust, Barnsley S75 2EP, UK.
  • Department of Pharmaceutical Marketing and Management, Faculty of Pharmacy, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
  • Discipline of Anatomy, Faculty of Dentistry, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.

ORCID-Profile: Maria Cristina Marinescu, Mihaela Simona Naidin, Adina Turcu-Stiolica

Zitieren

APA

Nicola, C. A., Marinescu, M. C., Alexandrescu, C., Firan, A. M., Alyamani, W., Naidin, M. S., Ciuluvica, R. C., Patrascu, R. A., Capraru, A. M., & Turcu-Stiolica, A. (2026). An Exploratory Study of Six-Month Niacinamide Supplementation on Macular Structure and Electrophysiology in Primary Open-Angle Glaucoma. Vision, 10(1), 7. https://doi.org/10.3390/vision10010007

Vancouver

Nicola CA, Marinescu MC, Alexandrescu C, Firan AM, Alyamani W, Naidin MS, et al. An Exploratory Study of Six-Month Niacinamide Supplementation on Macular Structure and Electrophysiology in Primary Open-Angle Glaucoma. Vision. 2026;10(1):7. doi:10.3390/vision10010007

BibTeX
@article{Nicola2026,
  author = {Nicola, Constantin Alin and Marinescu, Maria Cristina and Alexandrescu, Cristina and Firan, Anne Marie and Alyamani, Walid and Naidin, Mihaela Simona and Ciuluvica, Radu Constantin and Patrascu, Radu Antoniu and Capraru, Anca Maria and Turcu-Stiolica, Adina},
  title = {An Exploratory Study of Six-Month Niacinamide Supplementation on Macular Structure and Electrophysiology in Primary Open-Angle Glaucoma},
  journal = {Vision},
  year = {2026},
  volume = {10},
  number = {1},
  pages = {7},
  doi = {10.3390/vision10010007}
}
Kostenlos starten →